WEST MICHAEL D 4
4 · AgeX Therapeutics, Inc. · Filed Mar 14, 2023
Insider Transaction Report
Form 4
WEST MICHAEL D
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2023-03-11$0.59/sh−1,060$625→ 41,982 total - Exercise/Conversion
Common Stock, $0.0001 par value
2023-03-11+3,125→ 43,042 total - Exercise/Conversion
Restricted Stock Units
2023-03-11−3,125→ 0 totalExercise: $0.00→ Common Stock (3,125 underlying)
Footnotes (3)
- [F1]Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.
- [F2]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F3]Restricted Stock Units vested on March 11, 2023.